July 2013 FDA Recall Drug by Watson Laboratories Inc
D-823-2013 - Subpotent drug

This Class III drug recall was voluntarily initiated by Watson Laboratories Inc on July 19, 2013 for the product Drug. The FDA reported the reason for recall as subpotent drug. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-823-2013

Reason for Recall
Subpotent drug: Two lots of Oxycodone and Acetaminophen Capsules, USP 5/500 mg are being recalled due to low out of specification (OOS) assay result obtained at expiry (24 months) for the oxycodone portion of the product.
Initiated
07-19-2013
Reported
07-31-2013
Quantity
1,260 bottles

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Watson Laboratories Inc
Oxycodone and Acetaminophen Capsules, USP 5mg/500 mg, packaged in a)100-count bottle (NDC 0591-0737-01), b) 500-count bottle (NDC 0591-0737-05), Rx only, Manufactured by Watson Laboratories, Inc., Corona, CA92880.

Batch or Lot Expiration Information

Lot# a) 444971A, Exp 8/13; b) 444973A, Exp 8/13